Pharma Two B Appoints Sheila Oren, M.D., M.B.A., as Chief Executive Officer
Dr. Oren Has 25 Years’ Experience in Global Drug Development Leadership; Proven Track Record in PD REHOVOT, Israel, Jan. 05,
Dr. Oren Has 25 Years’ Experience in Global Drug Development Leadership; Proven Track Record in PD REHOVOT, Israel, Jan. 05,
Rehovot, Israel – February 18, 2020 – Pharma Two B Ltd., a privately held company developing innovative therapeutics based on
Based on positive data from a Phase IIb pivotal study suggesting that P2B001 may offer effective therapy with minimal side
REHOVOTH, Israel, February 27, 2017 — Pharma Two B Ltd., a privately held biopharmaceutical company focused on developing treatments for
Rehovoth, Israel, June 30, 2015 — Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously
Rehovoth, Israel, June 30, 2015 — Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously
http://bit.ly/gS5LF5